Jennier Domey, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 65 S Main St Ste 1, Waterbury, VT 05676 Phone: 802-882-8777 |
Dr. Raymond Joseph Vanvoorhis, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 104 S Main St, Waterbury, VT 05676 Phone: 802-244-7336 |
Northern Lights Family Chiropractic Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 65 S Main St Ste 1, Waterbury, VT 05676 Phone: 802-882-8777 |
Dr. Keith Heinz Schaller, D.C. Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 65 S Main St, Suite 2, Waterbury, VT 05676 Phone: 802-244-1365 Fax: 802-244-0840 |
Marion M Fraser Dc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 141 S Main St, Waterbury, VT 05676 Phone: 802-825-6068 |
Movewell Spine & Sport, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 46 S Main St, Suite 2, Waterbury, VT 05676 Phone: 802-244-8877 |
Sports & Family Chiropractic Ltd Chiropractor Medicare: Medicare Enrolled Practice Location: 65 S Main St, Suite 2, Waterbury, VT 05676 Phone: 802-244-1365 Fax: 802-244-0840 |
News Archive
Researchers at the Johns Hopkins University School of Medicine and elsewhere have found that genetic differences may account for why zinc supplements are more beneficial to some people than to others for the prevention and control of diabetes. The results of their pilot study of a population of Old Order Amish is believed to be the first to point out the relevance of small genetic differences in response to zinc supplementation at play in diabetes management.
A new study in the January issue of the Journal of Vascular Surgery(®), published by the Society for Vascular Surgery®, reveals robust epidemiological evidence that hereditary factors contribute to aneurysm formation in twins.
Tuberculosis remains one of deadliest infectious diseases of humans, killing 50% of individuals when left untreated. Even today, TB causes 1-2 million deaths every year mainly in developing countries. Multidrug-resistance is a growing threat in the fight against the disease.
Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.
The Foundation for Art & Healing today releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), a gathering of luminaries from the medical, arts and public health sectors regarding the connection between creative engagement and cardiac health. Held during the summer of 2009 in New York, the goal of the meeting was to draw on research and clinical expertise as well as the direct experiences of cardiac patients who have found creative endeavors to aid in their own personal healing processes.
› Verified 5 days ago